Link Pharma Chem Limited (BOM:524748)
India · Delayed Price · Currency is INR 27.50
+1.30 (4.96%)
At close: Aug 21, 2026
Link Pharma Chem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 283.85 | 274.32 | 254.33 | 298.98 | 387.58 | 535.61 |
| 283.85 | 274.32 | 254.33 | 298.98 | 387.58 | 535.61 | |
Revenue Growth | 16.32% | 7.86% | -14.93% | -22.86% | -27.64% | 53.85% |
Cost of Revenue | 122.55 | 112.91 | 128.97 | 172.93 | 221.75 | 372.08 |
Gross Profit | 161.3 | 161.41 | 125.37 | 126.05 | 165.83 | 163.53 |
Selling, General & Admin | 61.5 | 60.88 | 53.92 | 55.16 | 56.89 | 57.82 |
Other Operating Expenses | 82.18 | 82.48 | 70.16 | 77.23 | 77.81 | 70.7 |
Operating Expenses | 157.03 | 156.36 | 133.51 | 142.89 | 147.88 | 137.79 |
Operating Income | 4.27 | 5.05 | -8.14 | -16.84 | 17.95 | 25.74 |
Interest Expense | -5.68 | -5.3 | -7.76 | -8.72 | -7.61 | -4.51 |
Interest & Investment Income | 0.38 | 0.38 | 0.62 | 0.64 | 1.13 | 1.18 |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.01 | 0.04 | - | 0.44 |
Other Non Operating Income (Expenses) | 0.31 | 0.31 | 0 | -0 | - | - |
EBT Excluding Unusual Items | -0.69 | 0.47 | -15.27 | -24.89 | 11.47 | 22.85 |
Gain (Loss) on Sale of Investments | 0.83 | 0.88 | 1.25 | 4.94 | -2.61 | 2.19 |
Gain (Loss) on Sale of Assets | - | - | - | 0.79 | - | 1.18 |
Pretax Income | 0.14 | 1.35 | -14.03 | -19.16 | 8.86 | 26.22 |
Income Tax Expense | 0.21 | 0.58 | -3.75 | -5.53 | 2.32 | 7.4 |
Net Income | -0.07 | 0.77 | -10.27 | -13.63 | 6.54 | 18.82 |
Net Income to Common | -0.07 | 0.77 | -10.27 | -13.63 | 6.54 | 18.82 |
Net Income Growth | - | - | - | - | -65.23% | 73.45% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | -0.08% | - | - | - | - | - |
EPS (Basic) | -0.02 | 0.17 | -2.31 | -3.07 | 1.47 | 4.24 |
EPS (Diluted) | -0.02 | 0.17 | -2.31 | -3.07 | 1.47 | 4.24 |
EPS Growth | - | - | - | - | -65.23% | 73.45% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 0.47 | 24.29 | -9.78 | -26 | -24.15 |
Free Cash Flow Per Share | - | 0.10 | 5.47 | -2.20 | -5.86 | -5.44 |
Gross Margin | 56.83% | 58.84% | 49.29% | 42.16% | 42.79% | 30.53% |
Operating Margin | 1.50% | 1.84% | -3.20% | -5.63% | 4.63% | 4.81% |
Profit Margin | -0.02% | 0.28% | -4.04% | -4.56% | 1.69% | 3.51% |
Free Cash Flow Margin | - | 0.17% | 9.55% | -3.27% | -6.71% | -4.51% |
EBITDA | 14.16 | 14.85 | 1.29 | -6.5 | 27.18 | 35.02 |
EBITDA Margin | 4.99% | 5.41% | 0.51% | -2.17% | 7.01% | 6.54% |
D&A For EBITDA | 9.89 | 9.8 | 9.43 | 10.34 | 9.23 | 9.28 |
EBIT | 4.27 | 5.05 | -8.14 | -16.84 | 17.95 | 25.74 |
EBIT Margin | 1.50% | 1.84% | -3.20% | -5.63% | 4.63% | 4.81% |
Effective Tax Rate | 147.52% | 43.08% | - | - | 26.20% | 28.22% |
Revenue as Reported | 287.28 | 276.35 | 256.2 | 305.38 | 386.11 | 540.25 |
Advertising Expenses | - | - | - | - | - | 0.09 |